Introduction COVID-19 has a wide range of clinical manifestations. Neurological
manifestations in COVID-19 patients were demonstrated during the pandemic, including …

Although some patients have persistent symptoms or develop new symptoms following
coronavirus disease 2019 (COVID‐19) infection, neuropsychiatric aspects of long COVID …

Importance Neuropsychiatric symptoms have been reported as a prominent feature of
postacute sequelae of COVID-19 (PASC), with common symptoms that include cognitive …

Background and Objective Little is known about trajectories of recovery 12 months after
hospitalization for severe COVID-19. Methods We conducted a prospective, longitudinal …

The novel coronavirus disease 19 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), can have two phases: acute (generally 4 weeks …

Background Post-acute sequelae of COVID-19 (PASC) includes a heterogeneous group of
patients with variable symptomatology, who may respond to different therapeutic …

Background Cognitive complaints are one of the most frequent symptoms reported in post-
acute sequelae of COVID-19 (PASC). The Montreal Cognitive Assessment (MoCA) has …

Background The pandemic has highlighted and exacerbated health inequities in both acute
coronavirus disease 2019 (COVID‐19) and its longer‐term sequelae. Given the …

Background Subjective and objective cognitive dysfunction are reported after COVID-19 but
with limited data on their congruence and associations with the severity of the acute disease …

Background Limited data exists evaluating predictors of long-term outcomes after
hospitalization for COVID-19. Methods We conducted a prospective, longitudinal cohort …